Skip to main content
MedPathMedPath Home
Clinical Trials/NCT02306239
NCT02306239
Unknown
Not Applicable

the Surgical Intensive Care Unit

Liu ZiMeng1 site in 1 country40 target enrollmentDecember 2014
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsTerlipressinSeptic Shock
InterventionsNorepinephrineTerlipressin
DrugsTerlipressinNorepinephrine

Overview

Phase
Not Applicable
Intervention
Norepinephrine
Conditions
Terlipressin
Sponsor
Liu ZiMeng
Enrollment
40
Locations
1
Primary Endpoint
intestinal function assessed by abdominal distension, intestinal bleeding, peritonitis, plasma DAO level, enteral nutrition
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaArms & InterventionsOutcomesSitesSimilar Trials

Overview

Brief Summary

Terlipressin becomes a vasopressin for septic shock. But some studies found it may lead to severe intesitnal complications such as intestinal ischemia. The investigators study was designed to find the effect of terlipressin on intestinal function in septic shock patients.

Registry
clinicaltrials.gov
Start Date
December 2014
End Date
August 2015
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Liu ZiMeng
Responsible Party
Sponsor Investigator
Principal Investigator

Liu ZiMeng

surgical intensive care unit

First Affiliated Hospital, Sun Yat-Sen University

Eligibility Criteria

Inclusion Criteria

  • •septic shock

Exclusion Criteria

  • •shock due to other reasons
  • •diagnosited intesitinal ischemia

Arms & Interventions

norepinephrine

patients received norepinephrine

Intervention: Norepinephrine

terlipressin

patients received terlipressin

Intervention: Terlipressin

Outcomes

Primary Outcomes

intestinal function assessed by abdominal distension, intestinal bleeding, peritonitis, plasma DAO level, enteral nutrition

Time Frame: 7 days

Study Sites (1)

Loading locations...

Similar Trials

Unknown
Not Applicable
Efficacy and Safety of Vasopressin Versus Terlipressin as a Second Vasopressor in Critically Ill Cirrhotics With Septic Shock- the VITEL-C TrialSeptic ShockCirrhosis, Liver
NCT05315557Institute of Liver and Biliary Sciences, India100
Completed
Phase 2
Terlipressin in Septic Shock in CirrhosisLiver CirrhosisSeptic Shock
NCT00628160Hospital Clinic of Barcelona72
Recruiting
Phase 2
Terlipressin for Refractory Septic ShockSeptic ShockRefractory ShockNorepinephrine Adverse Reaction
NCT04339868Mahidol University130
Unknown
Phase 4
Evaluation of Early Association of Terlipressin and Norepinephrine During Septic Shock; the TerliNor StudySeptic Shock
NCT03336814Assistance Publique Hopitaux De Marseille40
Unknown
Not Applicable
Continuos Terlipressin Infusion in Septic ShockSeptic Shock
NCT01697410First Affiliated Hospital, Sun Yat-Sen University1,000